nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—pancreatic cancer—bile duct cancer	0.589	1	CtDrD
Docetaxel—EGFR—bile duct cancer	0.343	1	CbGaD
Docetaxel—ABCC2—bile duct—bile duct cancer	0.0045	0.149	CbGeAlD
Docetaxel—ABCC2—bile—bile duct cancer	0.00346	0.114	CbGeAlD
Docetaxel—KIF11—lymph node—bile duct cancer	0.00122	0.0403	CbGeAlD
Docetaxel—MAP4—pancreas—bile duct cancer	0.00115	0.038	CbGeAlD
Docetaxel—NR1I2—liver—bile duct cancer	0.00112	0.037	CbGeAlD
Docetaxel—MAP2—pancreas—bile duct cancer	0.000908	0.03	CbGeAlD
Docetaxel—MAP4—liver—bile duct cancer	0.000734	0.0242	CbGeAlD
Docetaxel—MAPT—lymph node—bile duct cancer	0.000715	0.0236	CbGeAlD
Docetaxel—TUBB4A—pancreas—bile duct cancer	0.000702	0.0231	CbGeAlD
Docetaxel—TUBB2B—pancreas—bile duct cancer	0.000678	0.0224	CbGeAlD
Docetaxel—EGFR—liver—bile duct cancer	0.000659	0.0217	CbGeAlD
Docetaxel—SLCO1B3—liver—bile duct cancer	0.000642	0.0212	CbGeAlD
Docetaxel—TUBB—pancreas—bile duct cancer	0.000642	0.0212	CbGeAlD
Docetaxel—TUBB2A—pancreas—bile duct cancer	0.000638	0.0211	CbGeAlD
Docetaxel—TUBB6—pancreas—bile duct cancer	0.00063	0.0208	CbGeAlD
Docetaxel—MAP2—liver—bile duct cancer	0.000578	0.0191	CbGeAlD
Docetaxel—MAP4—lymph node—bile duct cancer	0.000563	0.0186	CbGeAlD
Docetaxel—TUBB4B—pancreas—bile duct cancer	0.000547	0.0181	CbGeAlD
Docetaxel—CYP3A7—liver—bile duct cancer	0.000542	0.0179	CbGeAlD
Docetaxel—BCL2—lymph node—bile duct cancer	0.000511	0.0169	CbGeAlD
Docetaxel—EGFR—lymph node—bile duct cancer	0.000505	0.0167	CbGeAlD
Docetaxel—SLC22A7—liver—bile duct cancer	0.000499	0.0165	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—liver—bile duct cancer	0.000461	0.0152	CbGeAlD
Docetaxel—TUBB4A—liver—bile duct cancer	0.000446	0.0147	CbGeAlD
Docetaxel—MAP2—lymph node—bile duct cancer	0.000443	0.0146	CbGeAlD
Docetaxel—TUBB—liver—bile duct cancer	0.000408	0.0135	CbGeAlD
Docetaxel—TUBB2A—liver—bile duct cancer	0.000406	0.0134	CbGeAlD
Docetaxel—TUBB6—liver—bile duct cancer	0.000401	0.0132	CbGeAlD
Docetaxel—ABCC10—liver—bile duct cancer	0.000351	0.0116	CbGeAlD
Docetaxel—TUBB4B—liver—bile duct cancer	0.000348	0.0115	CbGeAlD
Docetaxel—TUBB4A—lymph node—bile duct cancer	0.000342	0.0113	CbGeAlD
Docetaxel—TUBB2B—lymph node—bile duct cancer	0.000331	0.0109	CbGeAlD
Docetaxel—TUBB—lymph node—bile duct cancer	0.000313	0.0103	CbGeAlD
Docetaxel—TUBB2A—lymph node—bile duct cancer	0.000311	0.0103	CbGeAlD
Docetaxel—TUBB6—lymph node—bile duct cancer	0.000307	0.0101	CbGeAlD
Docetaxel—CYP3A5—pancreas—bile duct cancer	0.0003	0.00988	CbGeAlD
Docetaxel—ABCC2—liver—bile duct cancer	0.000282	0.00929	CbGeAlD
Docetaxel—CYP1B1—liver—bile duct cancer	0.000276	0.0091	CbGeAlD
Docetaxel—ABCC10—lymph node—bile duct cancer	0.000269	0.00887	CbGeAlD
Docetaxel—TUBB4B—lymph node—bile duct cancer	0.000267	0.00881	CbGeAlD
Docetaxel—ABCC1—liver—bile duct cancer	0.000248	0.00818	CbGeAlD
Docetaxel—ABCC2—lymph node—bile duct cancer	0.000216	0.00712	CbGeAlD
Docetaxel—CYP1B1—lymph node—bile duct cancer	0.000211	0.00698	CbGeAlD
Docetaxel—ABCG2—liver—bile duct cancer	0.000205	0.00677	CbGeAlD
Docetaxel—CYP3A5—liver—bile duct cancer	0.000191	0.00629	CbGeAlD
Docetaxel—ABCC1—lymph node—bile duct cancer	0.00019	0.00627	CbGeAlD
Docetaxel—ABCB1—pancreas—bile duct cancer	0.000159	0.00525	CbGeAlD
Docetaxel—ABCG2—lymph node—bile duct cancer	0.000157	0.00519	CbGeAlD
Docetaxel—CYP3A4—liver—bile duct cancer	0.000143	0.00472	CbGeAlD
Docetaxel—ABCB1—liver—bile duct cancer	0.000101	0.00334	CbGeAlD
Docetaxel—ABCB1—lymph node—bile duct cancer	7.77e-05	0.00256	CbGeAlD
Docetaxel—TUBB6—Metabolism of proteins—MMP2—bile duct cancer	2.63e-05	0.000716	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	2.61e-05	0.000709	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—HRAS—bile duct cancer	2.6e-05	0.000706	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MET—bile duct cancer	2.59e-05	0.000705	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—MMP2—bile duct cancer	2.54e-05	0.000691	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—NRAS—bile duct cancer	2.52e-05	0.000686	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	2.51e-05	0.000683	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—NRAS—bile duct cancer	2.51e-05	0.000682	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HRAS—bile duct cancer	2.51e-05	0.000681	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—NRAS—bile duct cancer	2.5e-05	0.000679	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—NRAS—bile duct cancer	2.49e-05	0.000676	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ERBB2—bile duct cancer	2.48e-05	0.000673	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—bile duct cancer	2.48e-05	0.000673	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—MMP2—bile duct cancer	2.46e-05	0.00067	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—bile duct cancer	2.45e-05	0.000666	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—NRAS—bile duct cancer	2.44e-05	0.000663	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IDH1—bile duct cancer	2.42e-05	0.000658	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—SMAD4—bile duct cancer	2.42e-05	0.000657	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—KRAS—bile duct cancer	2.42e-05	0.000656	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—MMP2—bile duct cancer	2.41e-05	0.000655	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL6—bile duct cancer	2.4e-05	0.000652	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—IDH2—bile duct cancer	2.36e-05	0.000641	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—NRAS—bile duct cancer	2.34e-05	0.000636	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—bile duct cancer	2.34e-05	0.000636	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—NRAS—bile duct cancer	2.34e-05	0.000636	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HRAS—bile duct cancer	2.33e-05	0.000634	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—NRAS—bile duct cancer	2.32e-05	0.00063	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—KRAS—bile duct cancer	2.31e-05	0.000628	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—KRAS—bile duct cancer	2.31e-05	0.000628	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—NRAS—bile duct cancer	2.3e-05	0.000624	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—FAR2—bile duct cancer	2.3e-05	0.000624	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—NRAS—bile duct cancer	2.29e-05	0.000622	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	2.29e-05	0.000621	CbGpPWpGaD
Docetaxel—EGFR—Disease—IDH1—bile duct cancer	2.28e-05	0.00062	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—IDH2—bile duct cancer	2.28e-05	0.00062	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—KRAS—bile duct cancer	2.27e-05	0.000618	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TGFB1—bile duct cancer	2.27e-05	0.000616	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL6—bile duct cancer	2.27e-05	0.000616	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.25e-05	0.00061	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL6—bile duct cancer	2.23e-05	0.000607	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.22e-05	0.000603	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—KRAS—bile duct cancer	2.17e-05	0.00059	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—NRAS—bile duct cancer	2.17e-05	0.000588	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—MMP2—bile duct cancer	2.16e-05	0.000588	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MMP2—bile duct cancer	2.16e-05	0.000588	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—KRAS—bile duct cancer	2.16e-05	0.000587	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—KRAS—bile duct cancer	2.16e-05	0.000587	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—bile duct cancer	2.16e-05	0.000587	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—KRAS—bile duct cancer	2.15e-05	0.000584	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—KRAS—bile duct cancer	2.14e-05	0.000582	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MMP9—bile duct cancer	2.12e-05	0.000577	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—bile duct cancer	2.11e-05	0.000573	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—KRAS—bile duct cancer	2.1e-05	0.00057	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—ERBB2—bile duct cancer	2.09e-05	0.000569	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	2.09e-05	0.000568	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—IDH2—bile duct cancer	2.07e-05	0.000564	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	2.07e-05	0.000563	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—IDH2—bile duct cancer	2.06e-05	0.000559	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—HRAS—bile duct cancer	2.05e-05	0.000558	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	2.05e-05	0.000556	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HGF—bile duct cancer	2.04e-05	0.000555	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—bile duct cancer	2.03e-05	0.000552	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—IDH1—bile duct cancer	2.03e-05	0.000551	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—ERBB2—bile duct cancer	2.02e-05	0.000549	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—KRAS—bile duct cancer	2.01e-05	0.000547	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	2.01e-05	0.000547	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—KRAS—bile duct cancer	2.01e-05	0.000547	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	2e-05	0.000544	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—KRAS—bile duct cancer	2e-05	0.000542	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—MMP2—bile duct cancer	1.98e-05	0.000538	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—KRAS—bile duct cancer	1.98e-05	0.000537	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—KRAS—bile duct cancer	1.97e-05	0.000535	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—IL6—bile duct cancer	1.97e-05	0.000534	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—HRAS—bile duct cancer	1.96e-05	0.000534	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—IDH1—bile duct cancer	1.96e-05	0.000533	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—GNAS—bile duct cancer	1.95e-05	0.000531	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—HRAS—bile duct cancer	1.93e-05	0.000525	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—ERBB2—bile duct cancer	1.9e-05	0.000515	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	1.89e-05	0.000515	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—SLC5A5—bile duct cancer	1.89e-05	0.000514	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NRAS—bile duct cancer	1.88e-05	0.000512	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—IL6—bile duct cancer	1.88e-05	0.000511	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—bile duct cancer	1.87e-05	0.000507	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—KRAS—bile duct cancer	1.86e-05	0.000506	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RNF43—bile duct cancer	1.86e-05	0.000505	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MET—bile duct cancer	1.85e-05	0.000503	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—IL6—bile duct cancer	1.85e-05	0.000503	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—HRAS—bile duct cancer	1.85e-05	0.000502	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—HRAS—bile duct cancer	1.84e-05	0.000499	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—HRAS—bile duct cancer	1.84e-05	0.000499	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—HRAS—bile duct cancer	1.83e-05	0.000497	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—HRAS—bile duct cancer	1.82e-05	0.000494	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—bile duct cancer	1.79e-05	0.000487	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—IDH1—bile duct cancer	1.78e-05	0.000485	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	1.78e-05	0.000485	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.77e-05	0.000482	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—IDH1—bile duct cancer	1.77e-05	0.00048	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—IL6—bile duct cancer	1.77e-05	0.00048	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—IL6—bile duct cancer	1.76e-05	0.000478	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TGFB1—bile duct cancer	1.75e-05	0.000476	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—IL6—bile duct cancer	1.75e-05	0.000475	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—IL6—bile duct cancer	1.74e-05	0.000473	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	1.72e-05	0.000468	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EGFR—bile duct cancer	1.72e-05	0.000466	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—bile duct cancer	1.71e-05	0.000465	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	1.71e-05	0.000465	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—bile duct cancer	1.71e-05	0.000465	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—bile duct cancer	1.7e-05	0.000461	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	1.68e-05	0.000458	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—bile duct cancer	1.68e-05	0.000457	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—bile duct cancer	1.67e-05	0.000455	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	1.64e-05	0.000445	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—IL6—bile duct cancer	1.64e-05	0.000445	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—IL6—bile duct cancer	1.64e-05	0.000445	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—MMP9—bile duct cancer	1.63e-05	0.000442	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—IL6—bile duct cancer	1.62e-05	0.000441	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—KRAS—bile duct cancer	1.62e-05	0.000441	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—bile duct cancer	1.62e-05	0.000439	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—IL6—bile duct cancer	1.61e-05	0.000437	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—IL6—bile duct cancer	1.6e-05	0.000435	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—bile duct cancer	1.6e-05	0.000434	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NRAS—bile duct cancer	1.59e-05	0.000433	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—bile duct cancer	1.58e-05	0.00043	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MMP2—bile duct cancer	1.54e-05	0.000419	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NRAS—bile duct cancer	1.54e-05	0.000418	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	1.52e-05	0.000412	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—IDH2—bile duct cancer	1.49e-05	0.000404	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GNAS—bile duct cancer	1.47e-05	0.000399	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	1.46e-05	0.000398	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	1.46e-05	0.000397	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	1.45e-05	0.000394	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—NRAS—bile duct cancer	1.44e-05	0.000392	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—bile duct cancer	1.44e-05	0.000392	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	1.43e-05	0.000388	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FAR2—bile duct cancer	1.42e-05	0.000384	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	1.4e-05	0.000381	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—bile duct cancer	1.4e-05	0.000381	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—GNAS—bile duct cancer	1.39e-05	0.000377	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—bile duct cancer	1.38e-05	0.000375	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—KRAS—bile duct cancer	1.37e-05	0.000373	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	1.36e-05	0.000369	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—ERBB2—bile duct cancer	1.35e-05	0.000368	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SLC5A5—bile duct cancer	1.34e-05	0.000363	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—bile duct cancer	1.32e-05	0.00036	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—KRAS—bile duct cancer	1.32e-05	0.00036	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL6—bile duct cancer	1.32e-05	0.000359	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SLC5A5—bile duct cancer	1.29e-05	0.000352	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFBR2—bile duct cancer	1.29e-05	0.00035	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—IDH1—bile duct cancer	1.28e-05	0.000347	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.25e-05	0.000341	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—KRAS—bile duct cancer	1.24e-05	0.000337	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SMAD4—bile duct cancer	1.22e-05	0.000331	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFBR2—bile duct cancer	1.21e-05	0.000329	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.21e-05	0.000329	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—bile duct cancer	1.21e-05	0.000329	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HGF—bile duct cancer	1.21e-05	0.000328	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ERBB2—bile duct cancer	1.19e-05	0.000325	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ERBB2—bile duct cancer	1.18e-05	0.00032	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SLC5A5—bile duct cancer	1.18e-05	0.00032	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SLC5A5—bile duct cancer	1.17e-05	0.000317	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—bile duct cancer	1.17e-05	0.000317	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MMP9—bile duct cancer	1.16e-05	0.000315	CbGpPWpGaD
Docetaxel—EGFR—Disease—SMAD4—bile duct cancer	1.15e-05	0.000312	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB2—bile duct cancer	1.15e-05	0.000312	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—bile duct cancer	1.12e-05	0.000306	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—IDH2—bile duct cancer	1.12e-05	0.000305	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IL6—bile duct cancer	1.12e-05	0.000303	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IL6—bile duct cancer	1.08e-05	0.000293	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	1.06e-05	0.000287	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—bile duct cancer	1.06e-05	0.000287	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GNAS—bile duct cancer	1.04e-05	0.000282	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	1.03e-05	0.000281	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—bile duct cancer	1.03e-05	0.00028	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	1.01e-05	0.000275	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—bile duct cancer	1.01e-05	0.000274	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GNAS—bile duct cancer	1.01e-05	0.000273	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—IDH1—bile duct cancer	9.65e-06	0.000262	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TGFB1—bile duct cancer	9.56e-06	0.00026	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	9.56e-06	0.00026	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GNAS—bile duct cancer	9.15e-06	0.000249	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—bile duct cancer	9.09e-06	0.000247	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GNAS—bile duct cancer	9.07e-06	0.000246	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOS2—bile duct cancer	9.07e-06	0.000246	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—bile duct cancer	8.96e-06	0.000243	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—bile duct cancer	8.86e-06	0.000241	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—bile duct cancer	8.73e-06	0.000237	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOS2—bile duct cancer	8.54e-06	0.000232	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	8.5e-06	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFBR2—bile duct cancer	8.49e-06	0.000231	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC5A5—bile duct cancer	8.43e-06	0.000229	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GNAS—bile duct cancer	8.19e-06	0.000223	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—bile duct cancer	8.16e-06	0.000222	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SMAD4—bile duct cancer	8.04e-06	0.000218	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—bile duct cancer	7.9e-06	0.000215	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—bile duct cancer	7.82e-06	0.000213	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—bile duct cancer	7.71e-06	0.000209	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—bile duct cancer	7.53e-06	0.000205	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—bile duct cancer	7.51e-06	0.000204	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—bile duct cancer	7.21e-06	0.000196	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—bile duct cancer	6.96e-06	0.000189	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—IDH2—bile duct cancer	6.91e-06	0.000188	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—bile duct cancer	6.82e-06	0.000185	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—bile duct cancer	6.67e-06	0.000181	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—bile duct cancer	6.65e-06	0.000181	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GNAS—bile duct cancer	6.55e-06	0.000178	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—bile duct cancer	6.55e-06	0.000178	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—bile duct cancer	6.43e-06	0.000175	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—bile duct cancer	6.39e-06	0.000174	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—bile duct cancer	6.37e-06	0.000173	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC5A5—bile duct cancer	6.36e-06	0.000173	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—bile duct cancer	6.28e-06	0.000171	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—bile duct cancer	6.27e-06	0.00017	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—IDH1—bile duct cancer	5.94e-06	0.000161	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—bile duct cancer	5.79e-06	0.000157	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—bile duct cancer	5.58e-06	0.000152	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—bile duct cancer	5.4e-06	0.000147	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—bile duct cancer	5.29e-06	0.000144	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—bile duct cancer	5.19e-06	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—bile duct cancer	4.99e-06	0.000136	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNAS—bile duct cancer	4.95e-06	0.000134	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—bile duct cancer	4.91e-06	0.000133	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—bile duct cancer	4.89e-06	0.000133	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—bile duct cancer	4.87e-06	0.000132	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—bile duct cancer	4.82e-06	0.000131	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—bile duct cancer	4.73e-06	0.000128	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—bile duct cancer	4.56e-06	0.000124	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—bile duct cancer	4.54e-06	0.000123	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—bile duct cancer	4.5e-06	0.000122	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—bile duct cancer	4.46e-06	0.000121	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—bile duct cancer	4.24e-06	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—bile duct cancer	4.21e-06	0.000114	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—bile duct cancer	4.06e-06	0.00011	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC5A5—bile duct cancer	3.92e-06	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—bile duct cancer	3.87e-06	0.000105	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—bile duct cancer	3.86e-06	0.000105	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—bile duct cancer	3.79e-06	0.000103	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—bile duct cancer	3.71e-06	0.000101	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—bile duct cancer	3.63e-06	9.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—bile duct cancer	3.58e-06	9.72e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—bile duct cancer	3.52e-06	9.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—bile duct cancer	3.42e-06	9.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—bile duct cancer	3.42e-06	9.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—bile duct cancer	3.18e-06	8.64e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNAS—bile duct cancer	3.05e-06	8.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—bile duct cancer	2.95e-06	8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—bile duct cancer	2.66e-06	7.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—bile duct cancer	2.62e-06	7.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—bile duct cancer	2.5e-06	6.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—bile duct cancer	2.4e-06	6.51e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—bile duct cancer	1.64e-06	4.45e-05	CbGpPWpGaD
